Callahan Advisors LLC Buys 6,368 Shares of IQVIA Holdings Inc. $IQV

Key Points

• Callahan Advisors LLC increased its stake in IQVIA Holdings Inc. by 17.2%, acquiring an additional 6,368 shares, bringing its total holdings to 43,475 shares valued at approximately $6.85 million.
• In recent insider trading, Keriann Cherofsky and Eric Sherbet sold shares, indicating a 15.87% and 17.59% decrease in their ownership, respectively.
• IQVIA's latest quarterly earnings reported $2.81 earnings per share, surpassing expectations and reflecting a 5.3% increase in revenue compared to the previous year.

Callahan Advisors LLC grew its stake in shares of IQVIA Holdings Inc. (NYSE:IQV - Free Report) by 17.2% in the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 43,475 shares of the medical research company's stock after acquiring an additional 6,368 shares during the period. Callahan Advisors LLC's holdings in IQVIA were worth $6,851,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of IQV. Brighton Jones LLC increased its holdings in IQVIA by 244.4% during the fourth quarter. Brighton Jones LLC now owns 3,575 shares of the medical research company's stock valued at $703,000 after buying an additional 2,537 shares during the period. GAMMA Investing LLC increased its holdings in IQVIA by 56.3% during the first quarter. GAMMA Investing LLC now owns 2,197 shares of the medical research company's stock valued at $387,000 after buying an additional 791 shares during the period. Wealth Enhancement Advisory Services LLC increased its holdings in IQVIA by 34.5% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 13,259 shares of the medical research company's stock valued at $2,338,000 after buying an additional 3,398 shares during the period. Dynamic Advisor Solutions LLC increased its holdings in IQVIA by 20.3% during the first quarter. Dynamic Advisor Solutions LLC now owns 1,770 shares of the medical research company's stock valued at $312,000 after buying an additional 299 shares during the period. Finally, Exchange Traded Concepts LLC increased its holdings in IQVIA by 2.8% during the first quarter. Exchange Traded Concepts LLC now owns 5,357 shares of the medical research company's stock valued at $944,000 after buying an additional 148 shares during the period. 89.62% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other news, insider Keriann Cherofsky sold 549 shares of the business's stock in a transaction on Wednesday, July 23rd. The shares were sold at an average price of $191.53, for a total transaction of $105,149.97. Following the sale, the insider directly owned 2,910 shares of the company's stock, valued at $557,352.30. The trade was a 15.87% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Eric Sherbet sold 5,800 shares of the business's stock in a transaction on Wednesday, July 23rd. The shares were sold at an average price of $190.05, for a total transaction of $1,102,290.00. Following the sale, the insider directly owned 27,178 shares in the company, valued at $5,165,178.90. This trade represents a 17.59% decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.60% of the stock is owned by insiders.

IQVIA Price Performance

Shares of IQV opened at $203.38 on Thursday. The firm has a market capitalization of $34.58 billion, a PE ratio of 29.43, a price-to-earnings-growth ratio of 2.25 and a beta of 1.32. The company has a debt-to-equity ratio of 2.45, a current ratio of 0.84 and a quick ratio of 0.84. IQVIA Holdings Inc. has a 1-year low of $134.65 and a 1-year high of $237.21. The company's fifty day moving average price is $190.38 and its 200-day moving average price is $168.79.

IQVIA (NYSE:IQV - Get Free Report) last announced its quarterly earnings data on Tuesday, July 22nd. The medical research company reported $2.81 earnings per share for the quarter, beating analysts' consensus estimates of $2.77 by $0.04. The firm had revenue of $4.02 billion for the quarter, compared to analyst estimates of $3.96 billion. IQVIA had a net margin of 7.88% and a return on equity of 30.05%. The business's quarterly revenue was up 5.3% compared to the same quarter last year. During the same period in the previous year, the company earned $2.64 earnings per share. IQVIA has set its FY 2025 guidance at 11.750-12.050 EPS. On average, equities research analysts predict that IQVIA Holdings Inc. will post 10.84 EPS for the current year.

Analyst Ratings Changes

IQV has been the topic of several research reports. Redburn Partners set a $214.00 price objective on shares of IQVIA in a report on Wednesday, September 3rd. William Blair reiterated an "outperform" rating on shares of IQVIA in a report on Wednesday, July 23rd. UBS Group increased their price objective on IQVIA from $185.00 to $225.00 and gave the company a "buy" rating in a report on Wednesday, July 23rd. Cowen reiterated a "buy" rating on shares of IQVIA in a report on Wednesday, July 23rd. Finally, Weiss Ratings reiterated a "hold (c)" rating on shares of IQVIA in a report on Wednesday, October 8th. One research analyst has rated the stock with a Strong Buy rating, eighteen have issued a Buy rating and five have issued a Hold rating to the company's stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average target price of $234.57.

IQVIA Company Profile

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.

Want to see what other hedge funds are holding IQV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for IQVIA Holdings Inc. (NYSE:IQV - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.